$1.37
-0.06 (-4.20%)
Open$1.43
Previous Close$1.43
Day High$1.47
Day Low$1.36
52W High$4.19
52W Low$1.09
Volume—
Avg Volume297.8K
Market Cap103.81M
P/E Ratio—
EPS$-1.97
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
+2,119.0% upside
Current
$1.37
$1.37
Target
$30.40
$30.40
$22.94
$30.40 avg
$39.68
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 5.98M | 24.88M | 53.29M |
| Net Income | -208,930,981 | -1,320,959,060 | -9,463,863 |
| Profit Margin | -3,492.3% | -5,603.4% | -17.8% |
| EBITDA | -150,601,218 | -1,395,170,020 | -11,859,784 |
| Free Cash Flow | — | — | -9,841,834 |
| Rev Growth | +183.3% | -45.3% | -6.8% |
| Debt/Equity | 10.79 | 2.17 | 0.20 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |